Start Date
May 31, 2010
Primary Completion Date
May 31, 2010
Study Completion Date
May 31, 2010
Oral rehydration fluid
Oral electrolyte solution or other clinically acceptable oral rehydration fluid, 5 to 10 mL of offered with encouragement every 5 to 10 minutes
Isotonic hydration fluid and recombinant human hyaluronidase
Single subcutaneous dose of 150 U recombinant human hyaluronidase, followed by infusion pump-delivered subcutaneous isotonic hydration fluid
Collaborators (1)
Halozyme Therapeutics
INDUSTRY
Baxter Healthcare Corporation
INDUSTRY